172 related articles for article (PubMed ID: 22648055)
1. "Legal highs"--toxicity in the clinical and medico-legal aspect as exemplified by suicide with bk-MBDB administration.
Rojek S; Kłys M; Strona M; Maciów M; Kula K
Forensic Sci Int; 2012 Oct; 222(1-3):e1-6. PubMed ID: 22648055
[TBL] [Abstract][Full Text] [Related]
2. Determination of the metabolites of the new designer drugs bk-MBDB and bk-MDEA in human urine.
Zaitsu K; Katagi M; Kamata HT; Kamata T; Shima N; Miki A; Tsuchihashi H; Mori Y
Forensic Sci Int; 2009 Jul; 188(1-3):131-9. PubMed ID: 19406592
[TBL] [Abstract][Full Text] [Related]
3. New challenges in toxicology of new psychoactive substances exemplified by fatal cases after UR-144 and UR-144 with pentedrone administration determined by LC-ESI-MS-MS in blood samples.
Rojek S; Korczyńska-Albert M; Kulikowska J; Kłys M
Arch Med Sadowej Kryminol; 2017; 67(2):104-120. PubMed ID: 29363897
[TBL] [Abstract][Full Text] [Related]
4. Fatality due to combined use of the designer drugs MDMA and PMA: a distribution study.
Dams R; De Letter EA; Mortier KA; Cordonnier JA; Lambert WE; Piette MH; Van Calenbergh S; De Leenheer AP
J Anal Toxicol; 2003; 27(5):318-22. PubMed ID: 12908947
[TBL] [Abstract][Full Text] [Related]
5. Fatality due to the use of a designer drug MDMA (Ecstasy).
Kłys M; Rojek S; Woźniak K; Rzepecka-Woźniak E
Leg Med (Tokyo); 2007 Jul; 9(4):185-91. PubMed ID: 17320458
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous analysis of six amphetamines and analogues in hair, blood and urine by LC-ESI-MS/MS. Application to the determination of MDMA after low ecstasy intake.
Chèze M; Deveaux M; Martin C; Lhermitte M; Pépin G
Forensic Sci Int; 2007 Aug; 170(2-3):100-4. PubMed ID: 17629643
[TBL] [Abstract][Full Text] [Related]
7. Fatal poisoning by MDMA (ecstasy) and MDEA: a case report.
Fineschi V; Masti A
Int J Legal Med; 1996; 108(5):272-5. PubMed ID: 8721431
[TBL] [Abstract][Full Text] [Related]
8. Development of a rapid LC-MS/MS method for direct urinalysis of designer drugs.
Bell C; George C; Kicman AT; Traynor A
Drug Test Anal; 2011; 3(7-8):496-504. PubMed ID: 21744513
[TBL] [Abstract][Full Text] [Related]
9. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling.
Liechti M
Swiss Med Wkly; 2015; 145():w14043. PubMed ID: 25588018
[TBL] [Abstract][Full Text] [Related]
10. Determination of a new designer drug, N-hydroxy-3,4-methylenedioxymethamphetamine and its metabolites in rats using ultra-performance liquid chromatography-tandem mass spectrometry.
Kikura-Hanajiri R; Kawamura M; Miyajima A; Sunouchi M; Goda Y
Forensic Sci Int; 2010 May; 198(1-3):62-9. PubMed ID: 20299167
[TBL] [Abstract][Full Text] [Related]
11. Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of 'legal high' packages containing synthetic cathinones.
Araújo AM; Valente MJ; Carvalho M; Dias da Silva D; Gaspar H; Carvalho F; de Lourdes Bastos M; Guedes de Pinho P
Arch Toxicol; 2015 May; 89(5):757-71. PubMed ID: 24903018
[TBL] [Abstract][Full Text] [Related]
12. Khat and synthetic cathinones: a review.
Valente MJ; Guedes de Pinho P; de Lourdes Bastos M; Carvalho F; Carvalho M
Arch Toxicol; 2014 Jan; 88(1):15-45. PubMed ID: 24317389
[TBL] [Abstract][Full Text] [Related]
13. Four fatalities involving 5-IT.
Seetohul LN; Pounder DJ
J Anal Toxicol; 2013 Sep; 37(7):447-51. PubMed ID: 23861338
[TBL] [Abstract][Full Text] [Related]
14. Ecstasy and suicide.
Fernando T; Gilbert JD; Carroll CM; Byard RW
J Forensic Sci; 2012 Jul; 57(4):1137-9. PubMed ID: 22372646
[TBL] [Abstract][Full Text] [Related]
15. An announced suicide with ecstasy.
Libiseller K; Pavlic M; Grubwieser P; Rabl W
Int J Legal Med; 2007 Jan; 121(1):40-3. PubMed ID: 16175411
[TBL] [Abstract][Full Text] [Related]
16. Retrospective Demonstration of 25I-NBOMe Acute Poisoning Using Hair Analysis.
Ameline A; Farrugia A; Raul JS; Kintz P
Curr Pharm Biotechnol; 2017; 18(10):786-790. PubMed ID: 29189143
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of designer drugs detected in the products purchased in fiscal year 2006].
Uchiyama N; Kikura-Hanajiri R; Kawahara N; Goda Y
Yakugaku Zasshi; 2008 Oct; 128(10):1499-505. PubMed ID: 18827471
[TBL] [Abstract][Full Text] [Related]
18. Interpretation of a 3,4-methylenedioxymethamphetamine (MDMA) blood level: discussion by means of a distribution study in two fatalities.
De Letter EA; Bouche MP; Van Bocxlaer JF; Lambert WE; Piette MH
Forensic Sci Int; 2004 May; 141(2-3):85-90. PubMed ID: 15062945
[TBL] [Abstract][Full Text] [Related]
19. Detection and quantification of new designer drugs in human blood: Part 2 - Designer cathinones.
Ammann D; McLaren JM; Gerostamoulos D; Beyer J
J Anal Toxicol; 2012 Jul; 36(6):381-9. PubMed ID: 22593565
[TBL] [Abstract][Full Text] [Related]
20. Analysis of psychoactive and intoxicating substances in legal highs.
Żukiewicz-Sobczak W; Zwoliński J; Chmielewska-Badora J; Krasowska E; Piątek J; Sobczak P; Wojtyła A; Fornal E; Kuczumow A; Biliński P
Ann Agric Environ Med; 2012; 19(2):309-14. PubMed ID: 22742807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
